Help advance the understanding and treatment of brain tumors.
Cedars-Sinai Researchers Target Cancer Stem Cells in Malignant Brain Tumors
Learn more about approaches to prevent brain cancer recurrence by attacking tumors at the source.
Regulation of Cancer-causing Protein Could Lead to New Therapeutic Targets
Brain Tumor Research results from the Cincinnati Cancer Center and University of Cincinnati Cancer Institute.
Next Front in Cancer Care: As More Patients Survive, Cancer Centers Handle Disease's Knock-On Effects
An article from The Wall Street Journal on cancer survivorship and long term effects.
Brain Cancer Treatment Promising
San Diego-based Tocagen's approach shrank tumors, improved function in trials.
The FDA Wants 23andMe To Stop Marketing Its Genetic Testing Kits
The FDA is ordering 23andMe to stop marketing its saliva collection kits for its personal genome service.
Data Presented at Society for Neuro-Oncology Annual Meeting Demonstrate Tocagen's Toca 511 Gene Therapy with Toca FC was Well Tolerated and Showed Antitumor Activity in Patients with High Grade Glioma
Additional Preclinical Studies Demonstrate Potential for Intravenous Administration of Toca 511 and Use in Combination with Temozolomide and Radiation
Study Demonstrates biOasis Technologies' Conjugate of Metastatic Cancer Drug, Herceptin, Penetrates Blood-Tumor Barrier 10 Times Greater Than Herceptin Alone
biOasis Technologies Inc., a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier, reported that new research
Study Finds Potential Treatment for Deadly Brain Cancer
Research findings from Northwestern University Feinberg School of Medicine.
University of Queensland's Institute for Molecular Bioscience Study Finds 50 Genes Linked to Type of Childhood Brain Tumor
Findings from a research study on medulloblastoma.
Study Opens Doors to Novel Treatments for Aggressive Brain Cancer
Research from the Ludwig Institute for Cancer Research.